Investigational sIPV

BIOLOGICAL2 trials

Sponsors

Sinovac Biotech Co., Ltd

Conditions

Poliomyelitis

Phase 3

An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants

CompletedNCT03526978

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2017-08-08End: 2018-04-18Updated: 2019-01-25

Unknown Phase

An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses

CompletedNCT04989231

Sinovac Biotech Co., LtdPoliomyelitis

Start: 2021-09-09End: 2022-12-25Updated: 2023-01-12

Related Papers

Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observational study.

2023-04-295 citations

Immunogenicity and Safety of a Sabin Strain–Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial

The Journal of Infectious Diseases2019-03-2932 citations